|
|
Article: Preeclampsia trial pegs risk factors for SGA neonates: VIP trial data also show additive aspects.(News)
- Article from:
- OB GYN News
- Article date:
- July 15, 2006
- Author:
CopyrightCOPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LISBON -- Smoking, high blood pressure, advanced maternal age, history of preeclampsia, and lack of folate supplementation all boosted the risk of small-for-gestational-age neonates, based on data collected in the Vitamins in Preeclampsia trial.
Another new analysis of results from this landmark trial showed that several of the risk factors for preeclampsia were additive, producing risks in some women of more than 30%, Dr. Andrew H. Shennan said at the 15th World Congress of the International Society for the Study of Hypertension in Pregnancy.
The Vitamins in Preeclampsia (VIP) trial assessed the impact of daily supplements of vitamins C and E in a study ...